Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

118 Pages (Click to Jump) V   1 2 3 4 > »    
 
  
Reply to this topic

AVH, AVITA MEDICAL LTD
nipper
post Posted: Nov 16 2019, 02:26 PM
  Quote Post


Posts: 6,325
Thanks: 2229


QUOTE
Bell Potter raised $120 million in institutional money for Avita Medical on Wednesday, just days after the skin regeneration biotech replaced residential aged care operator Aveo at the arse end of the ASX200.

Fortuitously, only two weeks earlier, Bell’s healthcare analyst John Hester had slapped a buy on the stock. On October 31, he upgraded Avita’s valuation from 69¢ to 83¢ per share. At its market capitalisation of $1.12 billion, it’s trading at 146 times revenue.

Hester’s research was labelled prominently, in red font, as “speculative”. Less prominently, was the disclosure that Bell Potter “acted as lead manager of [Avita’s] 2017 capital raise of $16.9 million and 2018 capital raise for $40 million and received fees for that service.”

Nine pages later, in the fine print: “Bell Potter Securities [and] its employees… may from time to time hold interests in the securities referred to in this document.” Oh, and (as we’ve previously noted) “John Hester owns 20,000 shares in AVH.” Of course he does. Squint and you’d almost miss it.

What isn’t mentioned (even if the prospect is broadly disclaimed, as above) is that Bell Potter’s director of institutional broking in Hong Kong, Adam White, is Avita Medical’s 20th largest shareholder. According to the FY19 annual report lodged on October 10, White owns 3.3 million shares, worth $1.95 million at Thursday’s close.

According to Bell’s deal sheet, its Avita offer was available only to investors in Australia and Hong Kong. Certainly looks like they’ve got the latter covered.

https://www.afr.com/rear-window/bell-potter...20191114-p53alk

- hmmmm



--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne

Said 'Thanks' for this post: odi01  
 
lion40
post Posted: Nov 12 2019, 11:30 PM
  Quote Post


Posts: 10
Thanks: 6


Thanks Odi01, just awesome!


 
odi01
post Posted: Nov 12 2019, 03:25 PM
  Quote Post


Posts: 656
Thanks: 1472


https://hotcopper.com.au/threads/powerful-c...ost_id=41379894

 
odi01
post Posted: Nov 11 2019, 09:36 PM
  Quote Post


Posts: 656
Thanks: 1472


https://www.afr.com/street-talk/avita-medic...20191111-p539e7

 
odi01
post Posted: Nov 11 2019, 03:40 PM
  Quote Post


Posts: 656
Thanks: 1472


https://hotcopper.com.au/documentdownload?i...eFxke92GA%3D%3D

 
lion40
post Posted: Nov 10 2019, 11:20 PM
  Quote Post


Posts: 10
Thanks: 6


Financial Update 🚀🚀🚀

For the quarter ended 30 September 2019, the company reported the following financial performance-

  • Total cash receipts of value A$5,237k, representing a growth of 4% (increase of A$197k) when compared to the previous quarter ended 30 June 2019.
  • Cash receipts from customers amounted to A$4,079k, up 16% (increase of A$565k) relative to previous quarter, attributable to growing sales in the US.
  • Total Cash collected from BARDA amounted to A$1,158k, declined by 24% (decrease of A$368) in comparison to the prior quarter.
  • Collective payments valued A$27.9 million have been received under the BARDA contract, through 30 September 2019.
  • Total net cash utilized in operating activities was A$7,037k, decrease by 33% decrease (or by A$3,393k) compared to the previous quarter.
  • As at 30 September 2019, cash and cash equivalents held by AVITA Medical amounted to A$22,656k.


 

sentifi.com

Share Cafe Sentifi Top themes and market attention on:


odi01
post Posted: Nov 10 2019, 05:24 PM
  Quote Post


Posts: 656
Thanks: 1472


https://kalkinemedia.com/2019/11/10/lens-ov...eturns-avh-pnv/

 
blackm3
post Posted: Nov 9 2019, 04:21 AM
  Quote Post


Posts: 313
Thanks: 443


In Reply To: odi01's post @ Nov 8 2019, 07:46 PM

Odi01 hey ,
Any thoughts on avh going foward in regards to shareprice or growth . Im learning as much as i can before i invest .
Many thanks
Blackm3

 
lion40
post Posted: Nov 8 2019, 09:10 PM
  Quote Post


Posts: 10
Thanks: 6


listed in October in Nasdaq and on 14 Nov in ASX200

Very Nice 🤑

 
odi01
post Posted: Nov 8 2019, 07:46 PM
  Quote Post


Posts: 656
Thanks: 1472


https://www.fool.com.au/2019/11/08/avita-me...to-the-asx-200/

 
 


118 Pages (Click to Jump) V   1 2 3 4 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING